Babcook; John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Babcook; John.The latest application filed is for "cytotoxic and anti-mitotic compounds, and methods of using the same".

Company Profile

4.15.20

Babcook; John - Vancouver CA
BABCOOK; JOHN - British Columbia CA
Babcook, John - Fremont CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies comprising C-terminal light chain polypeptide extensions and conjugates and methods of use thereof Grant 11,208,497 - Babcook , et al. December 28, 2	2021-12-28
VAR2CSA-drug conjugates Grant 10,675,355 - Rich , et al.	2020-06-09
Compositions and methods for the treatment of platinum-drug resistant cancer Grant 10,517,958 - Babcook , et al. Dec	2019-12-31
Cytotoxic And Anti-mitotic Compounds, And Methods Of Using The Same App 20190269785 - WINTERS; Geoffrey C. ; et al.	2019-09-05
Cytotoxic and anti-mitotic compounds, and methods of using the same Grant 10,201,614 - Winters , et al. Feb	2019-02-12
Compositions And Methods For The Treatment Of Platinum-drug Resistant Cancer App 20180193473 - BABCOOK; John ; et al.	2018-07-12
Var2csa-drug Conjugates App 20180117163 - RICH; James R. ; et al.	2018-05-03
Var2csa-drug Conjugates App 20170246310 - RICH; James R. ; et al.	2017-08-31
Antibodies Comprising C-terminal Light Chain Polypeptide Extensions And Conjugates And Methods Of Use Thereof App 20170008970 - BABCOOK; John ; et al.	2017-01-12
Cytotoxic and anti-mitotic compounds, and methods of using the same Grant 9,522,876 - Winters , et al. December 20, 2	2016-12-20
Cytotoxic And Anti-mitotic Compounds, And Methods Of Using The Same App 20160038606 - WINTERS; Geoffrey C. ; et al.	2016-02-11
Anti-GCC antibody molecules and related compositions and methods Grant 8,785,600 - Nam , et al. July 22, 2	2014-07-22
Targeted binding agents against B7-H1 Grant 8,779,108 - Queva , et al. July 15, 2	2014-07-15
High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such Antibodies App 20140105905 - Babcook; John ; et al.	2014-04-17
Il-18 Binding Proteins App 20140088296 - Ghayur; Tariq ; et al.	2014-03-27
High affinity fully human monoclonal antibodies to interleukin-8 Grant 8,604,174 - Babcook , et al. December 10, 2	2013-12-10
IL-18 binding proteins Grant 8,431,130 - Ghayur , et al. April 30, 2	2013-04-30
Targeted Binding Agents Against B7-H1 App 20130034559 - Queva; Christophe ; et al.	2013-02-07
IL-18 binding proteins Grant 7,968,684 - Ghayur , et al. June 28, 2	2011-06-28
Anti-gcc Antibody Molecules And Related Compositions And Methods App 20110110936 - Nam; Samuel S. ; et al.	2011-05-12
Il-18 Binding Proteins App 20100291088 - Ghayur; Tariq ; et al.	2010-11-18
Targeted Binding Agents Directed To Cd105 And Uses Thereof App 20100196398 - GAZIT-BORNSTEIN; GADI ; et al.	2010-08-05
Identification of high affinity molecules by limited dilution screening Grant 7,754,433 - Babcook , et al. July 13, 2	2010-07-13
High Affinity Fully Human Monoclonal Antibodies To Interleukin-8 And Epitopes For Such Antibodies App 20090130110 - Babcook; John ; et al.	2009-05-21
IL-18 binding proteins App 20050147610 - Ghayur, Tariq ; et al.	2005-07-07
IL-18 binding proteins App 20050100965 - Ghayur, Tariq ; et al.	2005-05-12
Method for production of a multimeric protein by cell fusion App 20040053359 - Ryll, Thomas ; et al.	2004-03-18
Method for production of a multimeric protein by cell fusion App 20040053363 - Ryll, Thomas ; et al.	2004-03-18
Identification of high affinity molecules by limited dilution screening App 20030186327 - Babcook, John ; et al.	2003-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.